formulary_notes
TL3 Regular · Birmingham, UK
Formulary and reimbursement. I track what is actually funded where, and I date every claim because it changes constantly.
Joined 6 September 2024 · last posted 3d · groups: wiki-editors
145 posts, newest first. Showing up to 150.
-
Reading a rodent study on a secretagogue without over-extrapolating — the long version Replied, post #62 · Compounds › Secretagogues & GH axis · 25 Jul 2026 · 12 likes Growth hormone secretagogues act on the ghrelin receptor or on the growth hormone releasing hormone receptor rather than supplying growth hormone, which is the…
-
Pooling trials with different estimands Replied, post #109 · Evidence › Meta-analyses · 19 Jul 2026 · 0 likes I had written a reply contradicting post #107 and deleted it. Here is what survived. The honest answer on pooling trials with different estimands is that it depends,…
-
Reference intervals: how they are constructed and why one in twenty flags — does this… Replied, post #17 · Clinical › Bloodwork · 15 Jul 2026 · 0 likes Good question, well framed, and I would like to see it answered properly.
-
[2026 update] Antibiotics and a course of something with delayed emptying Replied, post #38 · Practice › Interactions · 13 Jul 2026 · 7 likes Marking my place. If it changes for me I will come back and say so.
-
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #100 · Compounds › Semaglutide · 11 Jul 2026 · 1 like Semaglutide and gastric emptying is one of those subjects where the general answer and the answer for a specific case diverge, and the thread will go in circles until…
-
Hair shedding at month three: mechanism and time course — the long version Replied, post #44 · Practice › Side effects · 10 Jul 2026 · 15 likes Post #43 is the version of this I will quote in future. One addition. Answering the Hair shedding question as asked, then the question I think is meant. As asked: yes,…
-
About the Hydration & electrolytes category Replied, post #3 · Nutrition & Training › Hydration & electrolytes · 9 Jul 2026 · 3 likes As a member rather than staff: the most useful thing I did when I started reading this category was to work through the tag pages rather than the topic list. The topic…
-
Molecular mass of semaglutide and why the figure differs between sources Replied, post #94 · Compounds › Semaglutide · 5 Jul 2026 · 0 likes Second-hand on molecular mass of semaglutide, so weight it accordingly — someone whose method I trust told me this and I have not verified it myself.
-
About the Announcements category Replied, post #7 · Meta › Announcements · 3 Jul 2026 · 2 likes Staff announcements, policy changes, and scheduled maintenance. Read-only except for questions clarifying what was announced.
-
Coming back to: Specificity, linearity, accuracy, precision, range, robustness — with… Replied, post #74 · Analytics › Method validation · 2 Jul 2026 · 18 likes Robustness testing deliberately varies the parameters most likely to drift — organic percentage, pH, temperature, flow — and shows the result does not. It is the part…
-
What a reversed-phase purity number actually is Replied, post #14 · Analytics › HPLC & UHPLC · 30 Jun 2026 · 29 likes Post #10 and I disagree about the size of the effect, not about the direction. Adding what did not work for me on reversed-phase purity number, since the failures never…
-
Micro-titration: a disputed topic, argued properly Replied, post #97 · Practice › Dosing & titration · 29 Jun 2026 · 7 likes Since micro-titration keeps coming up, it should probably be a maintained page rather than a recurring thread. I am happy to draft it if someone with more direct…
-
Angle of injection and whether 90 degrees is always right — the long version Replied, post #32 · Practice › Administration · 26 Jun 2026 · 20 likes Leak-back after withdrawal: a small amount of liquid on the skin after withdrawal is ordinary. Whether you lost a "meaningful" dose depends on concentration and your…
-
Heart failure with preserved ejection fraction: symptom endpoints Replied, post #10 · Clinical › Comorbidities · 26 Jun 2026 · 1 like Building on post #7 rather than restating it. Heart failure with preserved ejection has been discussed here with more heat than it deserves, mostly because two…
-
Batch numbers that do not match the vial label — what changed since Replied, post #44 · Sourcing › Red flags · 22 Jun 2026 · 0 likes Useful. I have added it to my own notes with the date on it.
-
Why we ask for units every single time, with three examples of what goes wrong Replied, post #58 · Start Here › How to Ask · 21 Jun 2026 · 0 likes What you have already read matters. Saying "I read the maintained page on this and I still have a gap" tells people they do not need to point you at the same resource…
-
Does a peptide degrade silently, with no visual change? Replied, post #50 · Practice › Storage & stability · 17 Jun 2026 · 10 likes What I can speak to on peptide is narrow, so I will keep it narrow rather than generalising from it. Beyond that boundary I do not know.
-
How to disagree with an answer you were given, well Replied, post #9 · marked as the solution · Start Here › How to Ask · 13 Jun 2026 · 19 likes Confirming post #8 from a second method, which matters more than confirming it from a second person. A question about somebody else's post should be a reply to that…
-
[2026 update] Travelling with an injectable: documentation and practicalities Replied, post #11 · Access › International · 12 Jun 2026 · 0 likes Where a jurisdiction has published guidance for clinicians, that document usually answers the practical questions better than any consumer-facing page.
-
Racemisation and why it is invisible to a mass measurement Replied, post #19 · Analytics › Impurities & related substances · 9 Jun 2026 · 0 likes Careful with the language on racemisation. "Not detected" and "not present" are different findings and the first is a statement about the method.
-
Why we ask for units every single time, with three examples of what goes wrong Replied, post #25 · Start Here › How to Ask · 7 Jun 2026 · 15 likes A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the identifiers before you post either.
-
Coming back to: Why a preprint's supplementary material is often the best part Replied, post #71 · Evidence › Preprints · 5 Jun 2026 · 10 likes Nothing to add, except that this is the answer I would give if asked.
-
A certificate whose chromatogram axes do not match its stated method — one year on Replied, post #54 · Sourcing › Red flags · 5 Jun 2026 · 19 likes I had written a reply contradicting post #53 and deleted it. Here is what survived. Documentation quality as a signal: a supplier that reports method identifiers,…
-
Injecting into an area that has become firm: why not to Replied, post #15 · Practice › Administration · 4 Jun 2026 · 31 likes That is a cleaner way of putting what I was circling around.
-
0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #61 · Devices › Syringes & needles · 4 Jun 2026 · 17 likes Coming back to post #59, because the follow-up matters more than the original answer. Adding a reference point for 0.3 ml versus 0.5 ml. Mine is a single case,…
-
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #34 · Practice › Storage & stability · 3 Jun 2026 · 0 likes A note on scope: what I am saying about reconstituted applies to the case in the first post and I would not extend it further without checking.
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ — does this still hold? Replied, post #21 · Sourcing › Independent verification · 1 Jun 2026 · 23 likes A note on how Janoshik gets discussed rather than on Janoshik itself: the confident posts get the replies and the careful ones get ignored, and the careful ones have…
-
Spreadsheets: an appreciation — what changed since Replied, post #56 · Lounge › Off topic · 30 May 2026 · 0 likes A digression that keeps occurring to me: the most-linked documents here are the dullest ones. Nothing gets cited like the unit-arithmetic page. I would not lead a…
-
Alcohol: what is documented and what is folklore Replied, post #13 · Practice › Interactions · 14 May 2026 · 0 likes Alcohol: no absolute contraindication but it raises gastrointestinal irritation risk and this drug class already does that. The conservative position during titration…
-
What I would want from a home test that does not exist yet — what changed since Replied, post #19 · Analytics › Home & field testing · 13 May 2026 · 22 likes What you can use home tests for: confirmation that a solution contains peptide (as opposed to being saline alone), rough screening for very different compounds…
-
Revisiting: Primary endpoint hierarchies and why order matters Replied, post #15 · Evidence › Trials · 9 May 2026 · 0 likes Absolute and relative effects answer different questions. Write down the event rate in each arm and the difference between them; everything quotable is derived from…
-
0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #25 · Devices › Syringes & needles · 27 Apr 2026 · 8 likes One caution on 0.3 ml versus 0.5 ml: everything above assumes the underlying documentation is what it claims to be. That assumption is doing real work and is rarely…
-
Blind submission and why it changes minds — the long version Replied, post #43 · Sourcing › Independent verification · 27 Apr 2026 · 20 likes Seconded. It reads as careful rather than confident, which is the right register.
-
Journal club: indirect comparison between two programmes, defended and attacked Replied, post #41 · Evidence › Journal club · 27 Apr 2026 · 0 likes Post #39 and I disagree about the size of the effect, not about the direction. I have been on both sides of the indirect comparison argument in this category within…
-
A parcel stationary at a customs facility for nine days Replied, post #52 · Sourcing › Logistics · 24 Apr 2026 · 17 likes Building on post #51 rather than restating it. Two claims get bundled together under parcel stationary and they need separating. The descriptive one — this is what was…
-
[2026 update] 0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #49 · Devices › Syringes & needles · 21 Apr 2026 · 11 likes Post #46 answers the question as asked. The question underneath it is different. A methods point on 0.3 ml versus 0.5 ml rather than a substantive one: if the…
-
Revisiting: The report format the maintainers ask for, and why each field is there Replied, post #54 · Sourcing › Vendor reports · 21 Apr 2026 · 18 likes Date the report: when the analysis was done matters. Material can degrade in storage. A report from two years ago is still useful but is not evidence about the current…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #18 · Practice › Reconstitution · 18 Apr 2026 · 0 likes Choose the concentration so that a typical dose lands on a graduation you can actually read. A dose that falls between two marks on a 1 mL barrel is a dose you will get…
-
Measurement error in home scales, with a worked standard deviation — the long version Replied, post #72 · Research Methods › Statistics · 7 Apr 2026 · 3 likes Seconded. It reads as careful rather than confident, which is the right register.
-
Pregnancy and pregnancy planning: contraindication and washout Replied, post #94 · Clinical › Special populations · 1 Apr 2026 · 24 likes Marking my place. If it changes for me I will come back and say so.
-
Second pass at: Metformin co-administration and additive GI effects Replied, post #76 · Practice › Interactions · 31 Mar 2026 · 24 likes Post #73 answers the question as asked. The question underneath it is different. What I would check first on Metformin co-administration is whether the thing being…
-
Specificity, linearity, accuracy, precision, range, robustness — with real criteria Started this topic · Analytics › Method validation · 20 Mar 2026 · 0 likes Specificity, linearity, accuracy, precision, range, robustness — with real criteria Writing it up because I had to work it out twice and would rather nobody else did.…
-
Pharmacy supply in the UK and the questions you will be asked Replied, post #81 · Regional › UK & Ireland · 18 Mar 2026 · 6 likes Genuine question rather than a rhetorical one: has anyone here actually observed pharmacy supply, as opposed to read about it? The thread is long and I cannot tell.
-
Coming back to: Training through a dose escalation week Replied, post #54 · Nutrition & Training › Resistance training · 17 Mar 2026 · 1 like The bit of Training through a dose escalation that nobody enjoys is that the answer changes depending on what you are trying to decide with it. Say what the decision is…
-
Why this subcategory is stricter about sourcing than most Replied, post #7 · Compounds › Secretagogues & GH axis · 11 Mar 2026 · 31 likes Injection-site reactions are reported more often in this family than for the incretins. Whether that is the compounds or the preparations they are typically supplied in…
-
Splitting a weekly dose in two: the pharmacokinetic argument against Replied, post #19 · Practice › Dosing & titration · 10 Mar 2026 · 4 likes Going back down a step is not a failure and the trials allowed it. Several protocols permitted a return to the previous dose for tolerability and then a second attempt…
-
Second pass at: Identical chromatograms across two different lots Replied, post #51 · Sourcing › Red flags · 8 Mar 2026 · 4 likes A document with no method identification is not evidence of anything wrong. It is evidence that the document cannot be checked, which is a different and weaker statement.
-
Interpreting a result that disagrees with the supplier's certificate Replied, post #131 · Sourcing › Independent verification · 20 Feb 2026 · 9 likes I read post #128 twice before replying, because I had assumed the opposite. PeptideMeter: purity analysis plus structured, dated supplier verification records. Produces…
-
Splitting an overlong document into two Replied, post #4 · Documentation › Wiki requests · 19 Feb 2026 · 5 likes I had written a reply contradicting post #2 and deleted it. Here is what survived. The honest answer on splitting an overlong document is that it depends, and the…
-
A 10 mg vial reconstituted three different ways, compared Replied, post #5 · Practice › Reconstitution · 15 Feb 2026 · 12 likes Post #4 is the version of this I will quote in future. One addition. Filter needles are worth considering if you are drawing from a glass ampoule and are pointless…
-
Journal club: SELECT, absolute risk, and how it was reported — a second dataset Replied, post #3 · Evidence › Journal club · 10 Feb 2026 · 5 likes SELECT (N Engl J Med 2023): Semaglutide cardiovascular outcomes without diabetes. The first outcome trial in people without diabetes, which decoupled the cardiovascular…
-
Type 2 diabetes and the largest part of the evidence base Replied, post #2 · Clinical › Comorbidities · 10 Feb 2026 · 9 likes Type 2 diabetes: I would want to see the raw numbers rather than the summary before agreeing. Summaries lose exactly the information that would settle this.
-
Measurement error in home scales, with a worked standard deviation — the long version Replied, post #25 · Research Methods › Statistics · 4 Feb 2026 · 0 likes This is the sort of exchange that makes the archive worth searching.
-
Second pass at: Adsorptive losses at low concentration, and why dilute solutions are… Replied, post #29 · Practice › Storage & stability · 30 Jan 2026 · 1 like Picking up post #28: that is the part I would want checked first. Visible particulate is a strong signal in the other direction: it is a reason to stop and ask rather…
-
Citation sweep results: how many references did not say what was claimed Replied, post #38 · Meta › Wiki maintenance · 30 Jan 2026 · 3 likes The number people quote for citation sweep results is a central estimate presented without its interval, and the interval is wide enough that the estimate is nearly…
-
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #44 · Clinical › Special populations · 23 Jan 2026 · 8 likes This follows post #43 rather than contradicting it. Reading this Pregnancy and pregnancy planning thread as someone who came in with a fixed view: the third and seventh…
-
Dizziness on standing and the electrolyte explanation — does this still hold? Replied, post #32 · Practice › Side effects · 5 Jan 2026 · 0 likes This is the first time the answer has come with its own limits attached. Appreciated.
-
What a certificate commits its issuer to — one year on Started this topic · Analytics › COA interpretation · 31 Dec 2025 · 0 likes What a certificate commits its issuer to — one year on — that is the question, and I have not found it answered plainly anywhere I have looked. A documentation question…
-
Recording a dissent on a document rather than suppressing it Started this topic · Documentation › Doc review · 30 Dec 2025 · 34 likes Recording a dissent on a document rather than suppressing it Writing it up because I had to work it out twice and would rather nobody else did. Recording a dissent, and…
-
Reference intervals: how they are constructed and why one in twenty flags Replied, post #27 · Clinical › Bloodwork · 25 Dec 2025 · 30 likes Everything in post #24 holds. The case it does not cover is the one I have. Reference intervals: constructed to contain the central 95% of a reference population, which…
-
Adolescents: a distinct evidence base — one year on Replied, post #46 · Clinical › Special populations · 22 Dec 2025 · 9 likes Post #42 describes the usual case. This is about the unusual one. Dedicated trials in under-studied populations are the only real remedy and several are ongoing, which…
-
Coming back to: Private prescribing in the UK: what is actually involved Started this topic · Regional › UK & Ireland · 18 Dec 2025 · 0 likes Private prescribing in the UK: what is actually involved Writing it up because I had to work it out twice and would rather nobody else did. I would like to know what…
-
Specification in the result column: why that is a meaningful error Replied, post #90 · Analytics › COA interpretation · 17 Dec 2025 · 4 likes "Not less than 98 per cent" is a specification. "98.3 per cent" is a result. A certificate carrying only the first has not told you what was measured. Reading it again,…
-
Older adults, sarcopenia risk, and the trade-off nobody quantifies — the long version Replied, post #65 · Clinical › Special populations · 10 Dec 2025 · 0 likes Helpful, and short, which on this subject is harder than long.
-
Documentation that appears only after payment Replied, post #100 · Sourcing › Red flags · 8 Dec 2025 · 5 likes Documentation: I have looked for the primary source twice and failed twice. Either it does not exist or it is somewhere I do not know to look, and I would like to know…
-
Follow-up: The lowest dose that does anything: is that a real question? Replied, post #73 · Practice › Dosing & titration · 9 Nov 2025 · 11 likes Writing down the date, the dose and the site each week takes fifteen seconds and is the single most useful record anyone here keeps. Memory reconstructs a titration…
-
Revisiting: Why tirzepatide titration schedules have more steps than semaglutide's Replied, post #24 · Compounds › Tirzepatide · 9 Nov 2025 · 1 like Careful with the language on tirzepatide titration schedules. "Not detected" and "not present" are different findings and the first is a statement about the method.
-
Dead volume across syringe and needle combinations Replied, post #15 · Devices › Syringes & needles · 24 Oct 2025 · 0 likes Following, with nothing to contribute beyond having asked the same thing elsewhere.
-
Follow-up: What a seizure notice actually says Replied, post #6 · Sourcing › Logistics · 24 Oct 2025 · 17 likes Anyone deciding whether a delay is a problem should ask what would change if they waited another week. Usually the answer is nothing.
-
AOD-9604 and the fragment hypothesis, revisited Replied, post #22 · Compounds › Other compounds · 20 Oct 2025 · 0 likes A methods point on AOD-9604 rather than a substantive one: if the comparison is not like for like, the difference you are measuring is the difference in method.
-
Sleep tracking data and its considerable limitations Replied, post #18 · Wellbeing › Sleep · 17 Oct 2025 · 0 likes Obstructive sleep apnoea: pre-existing OSA can worsen with weight before it improves (apnoea-hypopnoea index goes up as soft tissue inflames before weight is lost).…
-
Second pass at: Programming during a large energy deficit Replied, post #41 · Nutrition & Training › Resistance training · 15 Oct 2025 · 16 likes Adding a note of thanks rather than an opinion. I did not know most of that.
-
The most useful thing you learned here that was not the answer you came for — a second… Replied, post #85 · Lounge › Off topic · 9 Oct 2025 · 24 likes Politics and public policy: healthcare policy that affects access to these compounds is relevant here. Partisan politics is not. It reads as pedantry until the day it…
-
Compounds this community declines to help with, and why Replied, post #41 · Compounds › Other compounds · 1 Oct 2025 · 0 likes Coming back to post #38, because the follow-up matters more than the original answer. This subcategory exists because some people will research compounds outside the…
-
Journal club: how we handle discontinuation in obesity trials — what changed since Replied, post #8 · Evidence › Journal club · 27 Sep 2025 · 15 likes The most common failure mode is spending fifty minutes on the effect size and ten on the population. Reversing that ratio would improve most sessions. Second-hand, so…
-
A preprint whose numbers changed substantially at publication Replied, post #65 · Evidence › Preprints · 24 Sep 2025 · 14 likes Post #63 describes the usual case. This is about the unusual one. Building anything durable on a preprint means committing to rebuild it. That is a reasonable trade for…
-
The nausea timeline across the first four weeks, with a tabulated log Replied, post #85 · Practice › Side effects · 23 Sep 2025 · 20 likes I would rather this thread reach "we do not know" about nausea timeline than reach a confident answer that nobody can support when asked.
-
Temperature loggers worth the money Replied, post #31 · Devices › Cold chain · 18 Sep 2025 · 32 likes Taking post #30 at face value and following it one step further. Temperature loggers worth the money sits at the boundary between what this community can usefully…
-
Titles that describe the question, not the situation — what changed since Replied, post #9 · Start Here › How to Ask · 11 Sep 2025 · 0 likes What I can speak to on Titles is narrow, so I will keep it narrow rather than generalising from it. Beyond that boundary I do not know.
-
Aggregated purity results across four services, with caveats — a second dataset Replied, post #2 · Data & Tools › Datasets · 6 Sep 2025 · 0 likes Practical experience of Aggregated purity results across four, offered as one case with the conditions stated, not as a general finding. Conditions first, because they…
-
Pooling trials with different estimands — what changed since Replied, post #21 · Evidence › Meta-analyses · 5 Sep 2025 · 10 likes I read post #19 twice before replying, because I had assumed the opposite. Posting my Pooling trials with different estimands numbers with the method attached so they…
-
Column chemistry choices for a 40-residue peptide Replied, post #23 · Analytics › HPLC & UHPLC · 28 Aug 2025 · 24 likes The practical version of column chemistry choices is three sentences long. The rigorous version is three pages and reaches the same conclusion with the conditions…
-
How the vendor documentation pages are maintained, and by whom — what changed since Replied, post #43 · Sourcing › Vendor reports · 20 Aug 2025 · 32 likes Reframing vendor documentation pages slightly, because I think the disagreement is about the question rather than the answer. If the question is "does it happen", yes.…
-
Second pass at: A history of disordered eating: proceeding carefully Replied, post #109 · Wellbeing › Mental health · 12 Aug 2025 · 18 likes Adding a reference point for history of disordered eating. Mine is a single case, collected without controls, and I am posting the method alongside it so it can be…
-
Analytical identity of BPC-157: a 15-mer with a simple mass Replied, post #2 · Compounds › Repair & healing peptides · 8 Aug 2025 · 2 likes Taking the opening post at face value and following it one step further. Acetate content can be a substantial fraction of the mass in a short peptide. A vial labelled 5…
-
Second pass at: Triple agonism: additive, synergistic, or neither? Replied, post #91 · Compounds › Retatrutide · 7 Aug 2025 · 0 likes Nausea and vomiting were dose-related in the phase 2 work, as they are throughout this class. What is not established is whether the tolerability profile differs from…
-
Why "any advice?" is the least effective ending for a post — the long version Replied, post #35 · Start Here › How to Ask · 7 Aug 2025 · 0 likes I had written a reply contradicting post #34 and deleted it. Here is what survived. Nobody minds being asked to explain a term. The people who use them most are the…
-
A friction point in the promotion workflow Replied, post #4 · Meta › Site feedback · 6 Aug 2025 · 0 likes Narrowing post #3, because the general version has more than one answer. An observation about friction point that I cannot explain and am posting anyway, on the…
-
Fatigue in the first month: how much is the drug and how much is intake — what changed… Replied, post #17 · Practice › Side effects · 4 Aug 2025 · 4 likes The arithmetic on Fatigue is the easy part and it is where the errors are, which is an uncomfortable combination. Show your working and someone will catch it.
-
How to research a compound with no human data without deceiving yourself Started this topic · Compounds › Other compounds · 29 Jul 2025 · 56 likes Asking directly, because I could not find a straight answer: How to research a compound with no human data without deceiving yourself Question about what the published…
-
Where the integrator drew the baseline, and how much it moved the number Started this topic · Analytics › HPLC & UHPLC · 26 Jul 2025 · 56 likes Where the integrator drew the baseline, and how much it moved the number — setting out what I have, and where I think it stops being reliable. Posting the method first,…
-
Research-use-only labelling: what it means and what it does not Replied, post #14 · Sourcing › Regulatory · 22 Jul 2025 · 15 likes Two people in this thread mean different things by research-use-only labelling and are disagreeing about the definition while believing they are disagreeing about the…
-
[2026 update] Cold solution and stinging: the simplest fix Replied, post #4 · Practice › Administration · 20 Jul 2025 · 32 likes If you have to inject at a different time of day than usual, that is a much smaller perturbation than it feels for a weekly compound with a week-long half-life.
-
Second pass at: Pharmacy supply in the UK and the questions you will be asked Replied, post #54 · Regional › UK & Ireland · 17 Jul 2025 · 3 likes Availability through a private route and availability through the public system are separate questions and both change independently.
-
A field-by-field walk through a certificate of analysis Replied, post #91 · Analytics › COA interpretation · 17 Jul 2025 · 24 likes Where I part company with post #89, and it is a narrow parting. A chromatogram supplied as a small image is legible for peak shape and not for baseline detail. That is…
-
Coming back to: Sample size calculations, read backwards from the published number Replied, post #53 · Evidence › Trials · 8 Jul 2025 · 1 like Post #51 describes the usual case. This is about the unusual one. Number needed to treat is only interpretable with the duration attached. The same NNT over one year…
-
Freeze-thaw and why one cycle is not the same as five — a second dataset Replied, post #3 · Practice › Storage & stability · 7 Jul 2025 · 25 likes The opening post put the caveat in the right place and I want to underline it. Freeze-thaw is one of those subjects where the general answer and the answer for a…
-
Second pass at: Isotonicity and what happens when you get it wrong Replied, post #2 · Pharmacology › Formulation chemistry · 2 Jul 2025 · 0 likes Picking up the opening post: that is the part I would want checked first. Two claims get bundled together under Isotonicity and they need separating. The descriptive…
-
High-resolution MS on aggregates and what it can see Replied, post #15 · Analytics › Mass spectrometry · 2 Jul 2025 · 13 likes Speaking only to high-resolution as I have actually seen it, rather than as it is usually described: the effect is real, it is smaller than the thread suggests, and the…
-
Why a compound being unapproved is not the same as being illegal to possess Replied, post #2 · Sourcing › Regulatory · 30 Jun 2025 · 21 likes Adding the measurement that the opening post says would settle it. Regulatory positions change: a compound's status today might differ from its status a year from now.…
-
[2026 update] What the GIP component of tirzepatide is thought to contribute, and how… Replied, post #77 · Compounds › Tirzepatide · 26 Jun 2025 · 18 likes The dual agonism is not a marketing framing — GIP receptor and GLP-1 receptor engagement are both demonstrable. What is genuinely unresolved is how much of the clinical…
-
The CagriSema phase 2 paper and what a fixed combination buys — the long version Replied, post #98 · Compounds › Cagrilintide & amylin analogues · 14 Jun 2025 · 18 likes The phase 3 combination programme is where the clinically interesting numbers will come from. Phase 2 established that the combination does something; the size of it in…
-
Coming back to: Why quantitation is the hard part, not detection Replied, post #15 · Analytics › Home & field testing · 13 May 2025 · 32 likes Documenting home checks with dates and lots makes them accumulate into something. Undocumented ones evaporate and get remembered selectively. The short answer was in…
-
Delayed gastric emptying and oral medication absorption: which drugs matter Replied, post #68 · Practice › Interactions · 1 May 2025 · 6 likes Everything in post #66 holds. The case it does not cover is the one I have. Alcohol is not contraindicated in the labelling and it does irritate a stomach that is…
-
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #86 · Devices › Cold chain · 16 Apr 2025 · 8 likes Repacking cold material into a domestic refrigerator promptly on arrival is the one step that is entirely within your control and the one most often delayed. I am aware…
-
Second pass at: Pharmacy supply in the UK and the questions you will be asked Replied, post #29 · Regional › UK & Ireland · 11 Apr 2025 · 12 likes I had written a reply contradicting post #25 and deleted it. Here is what survived. Adding a small correction to the Pharmacy supply summary above rather than a…
-
Journal club: STEP 4 and what a withdrawal design can prove Replied, post #20 · Evidence › Journal club · 7 Apr 2025 · 0 likes Confirming post #19 from a second method, which matters more than confirming it from a second person. The most common failure mode is spending fifty minutes on the…
-
Reading order for a first week here, and what to skip until later Replied, post #69 · Start Here › Welcome · 6 Apr 2025 · 26 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
Documenting a supplier's response to a discrepancy — does this still hold? Replied, post #4 · Sourcing › Vendor reports · 18 Mar 2025 · 25 likes Dosing and purity: a vial that is 99% pure might contain 80% of its label claim if the other mass is water, counter-ion, and excipient. Purity and content are…
-
Consistent declarations and why they matter more than clever ones Replied, post #163 · Sourcing › Logistics · 11 Mar 2025 · 4 likes Post #160 answers the question as asked. The question underneath it is different. Anyone deciding whether a delay is a problem should ask what would change if they…
-
Pharmaceutical compounding rules, summarised from primary sources Replied, post #130 · Sourcing › Regulatory · 5 Mar 2025 · 0 likes Read the primary regulatory document rather than a summary of it. Summaries in this area lag by a year routinely and by longer occasionally. Two sources, same…
-
Consistent declarations and why they matter more than clever ones Replied, post #127 · Sourcing › Logistics · 5 Mar 2025 · 2 likes Thank you for taking the time. That was more work than a reply usually is.
-
Anxiety in the first weeks: drug, situation, or both Replied, post #57 · Wellbeing › Mental health · 3 Mar 2025 · 10 likes Coming back to post #56, because the follow-up matters more than the original answer. Motivation and expectation: starting with clear motivation and realistic…
-
Pharmaceutical compounding rules, summarised from primary sources Replied, post #50 · Sourcing › Regulatory · 1 Mar 2025 · 0 likes On pharmaceutical compounding rules: the maintained page in the documentation commons covers the general case with citations and a review date, which is more reliable…
-
SNAC and the mechanism of oral peptide absorption — the long version Replied, post #33 · Compounds › Oral incretins · 1 Mar 2025 · 0 likes Oral semaglutide's bioavailability is low and variable, which is why the dose numbers are an order of magnitude different from the injectable. That is a formulation…
-
Biased agonism: a real phenomenon, an over-used explanation Replied, post #9 · Pharmacology › Receptor biology · 25 Feb 2025 · 0 likes Practical note on biased agonism: write down what you expect before you look. The number of times I have found what I went looking for is higher than chance would allow.
-
Canadian access and provincial variation Replied, post #36 · Regional › North America · 30 Jan 2025 · 0 likes Adding the measurement that post #34 says would settle it. I have no financial interest in anything named in this thread and I want to say so before I comment on…
-
[2026 update] Lipid changes during rapid weight loss: the expected trajectory Replied, post #23 · Clinical › Bloodwork · 18 Jan 2025 · 13 likes Lipid changes during rapid weight is one of those subjects where the general answer and the answer for a specific case diverge, and the thread will go in circles until…
-
Coming back to: Request: tag synonyms surfaced in search Started this topic · Meta › Feature requests · 12 Jan 2025 · 22 likes Request: tag synonyms surfaced in search Writing it up because I had to work it out twice and would rather nobody else did. Tag synonyms surfaced in search — I have the…
-
Follow-up: Individual participant data versus aggregate data Replied, post #50 · Evidence › Meta-analyses · 10 Jan 2025 · 0 likes Funnel plots: a plot of study effect size versus sample size that helps detect publication bias. If small studies are missing on the negative side, the funnel is…
-
Oxidation pathways for methionine and tryptophan Replied, post #40 · Analytics › Impurities & related substances · 29 Dec 2024 · 5 likes Offering a way to settle oxidation pathways for methionine rather than another opinion about it. Two measurements, taken the same way, a fortnight apart. If the…
-
A request that was declined, and the reasoning Started this topic · Documentation › Wiki requests · 27 Dec 2024 · 17 likes On the subject in the title: A request that was declined, and the reasoning Working notes rather than a conclusion. Process question about how this site works. I have…
-
Revisiting: Semaglutide formulation: what is in the licensed product besides the peptide Replied, post #14 · Compounds › Semaglutide · 18 Dec 2024 · 2 likes Confirming post #13 from a second method, which matters more than confirming it from a second person. On alcohol: the labelling does not contraindicate it, but it…
-
Second pass at: Choosing a concentration on purpose rather than by accident Replied, post #47 · Practice › Reconstitution · 14 Dec 2024 · 18 likes The best check on any reconstitution calculation is to do it twice by two different routes — mass per volume, then volume per dose — and see whether they agree. They…
-
When to suspect the method rather than the sample Replied, post #49 · Analytics › Method validation · 11 Dec 2024 · 5 likes Reading rather than answering, but this is the post I would point somebody at.
-
Fixed versus detachable needles: the trade-offs Replied, post #31 · Devices › Syringes & needles · 3 Dec 2024 · 7 likes Practical experience of fixed versus detachable needles, offered as one case with the conditions stated, not as a general finding. Conditions first, because they are…
-
Research-use-only status: what it means legally and practically — a second dataset Replied, post #25 · Compounds › Other compounds · 23 Nov 2024 · 24 likes Two claims get bundled together under Research-use-only status and they need separating. The descriptive one — this is what was observed — is usually well supported.…
-
Follow-up: Where the four-week escalation interval comes from, and what it is not Replied, post #104 · Practice › Dosing & titration · 14 Nov 2024 · 18 likes The four-week escalation interval is a convention from the pivotal trials, not a pharmacological constant. The pharmacological argument is that with a week-long…
-
Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Replied, post #106 · Compounds › Other compounds · 10 Nov 2024 · 10 likes Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which puts it in a different evidential category from most of its…
-
Signs of dehydration worth acting on Replied, post #38 · Safety › Adverse events · 1 Nov 2024 · 11 likes My understanding of signs of dehydration worth acting is a few years old and may have been superseded. If it has been, I would genuinely like to know rather than keep…
-
SURPASS-2 and the comparator dose question that will not go away Replied, post #43 · Compounds › Tirzepatide · 28 Oct 2024 · 6 likes Research-use-only tirzepatide is not approved for human use and is not made to pharmaceutical standards. Anyone discussing it here is describing what they did, not…
-
Transporting a vial for a weekend away Replied, post #2 · Practice › Storage & stability · 22 Oct 2024 · 9 likes Nobody has said the unglamorous part of transporting a vial yet, so: most of the variation is explained by things that are boring to write about and easy to check.
-
Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Replied, post #57 · Compounds › Other compounds · 18 Oct 2024 · 0 likes Something worth flagging about Melanocortin agonists: the strongest-sounding claims in this thread are the ones with no source attached, which is the usual pattern and…
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #76 · Clinical › Prescriber conversations · 12 Oct 2024 · 31 likes Bringing a record of symptoms with dates and severities makes an assessment materially easier and is the single most useful preparation.
-
Requesting a page: what makes a good request — what changed since Replied, post #64 · Documentation › Wiki requests · 11 Oct 2024 · 0 likes A request that says what the page should not cover is unusually helpful, because scope creep is what kills these. The conclusion is tentative; the arithmetic underneath…
-
Second pass at: Hoarding and why it makes a shortage worse Replied, post #24 · Access › Shortages · 9 Oct 2024 · 32 likes Pharmacy-level availability varies enormously during a shortage, so two honest accounts from the same city can be opposite.
-
Requesting a page: what makes a good request — what changed since Replied, post #15 · Documentation › Wiki requests · 9 Oct 2024 · 0 likes Name a willing maintainer in the request. Point three of the criteria stops more nominations than the other three combined.
-
Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Replied, post #26 · Compounds › Other compounds · 1 Oct 2024 · 12 likes If someone has run Melanocortin agonists properly I would rather read that than my own reconstruction of it. Posting mine only because the thread has gone quiet.
-
Why a preprint's supplementary material is often the best part Replied, post #29 · Evidence › Preprints · 19 Sep 2024 · 0 likes Building anything durable on a preprint means committing to rebuild it. That is a reasonable trade for a fast-moving question and it should be an explicit one.
-
Progressive overload when the scale is falling — one year on Replied, post #58 · Nutrition & Training › Resistance training · 15 Sep 2024 · 0 likes Post #56 put the caveat in the right place and I want to underline it. Anybody returning after a break should expect to start lower than they left, and expecting…
-
Coming back to: Purity assay versus content assay: two different numbers Replied, post #77 · Analytics › COA interpretation · 14 Aug 2024 · 25 likes Picking up post #74: that is the part I would want checked first. A document that puts the specification in the result column has told you the release criterion rather…
-
Coming back to: Purity assay versus content assay: two different numbers Replied, post #28 · Analytics › COA interpretation · 10 Aug 2024 · 4 likes Post #27 is right about the mechanism and I think understates the practical bit. The distinction between release testing and characterisation is one industrial…
-
The most common factual error about semaglutide on the internet Replied, post #3 · Compounds › Semaglutide · 9 Aug 2024 · 26 likes The C-cell question: semaglutide triggered medullary thyroid carcinoma in rodent toxicology studies. A signal in rodents does not automatically appear in humans, but it…
-
How this community labels and discusses unrefereed work Replied, post #83 · Evidence › Preprints · 14 Jul 2024 · 14 likes Reframing community labels slightly, because I think the disagreement is about the question rather than the answer. If the question is "does it happen", yes. If it is…
-
Assessing a warm arrival: the decision process — one year on Replied, post #65 · Sourcing › Logistics · 31 May 2024 · 3 likes Coming back to post #62, because the follow-up matters more than the original answer. Packaging integrity on arrival: if a parcel arrives with compromised packaging,…